Registry of Lobbyists

Monthly Communication Report

371-516518

Organization: Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration: 782797-371-92
Communication date: 2021-11-26
Posted date: 2021-12-03

Designated Public Office Holders who participated in the communication: Dylan Marando, Senior Policy Advisor
Prime Minister's Office (PMO)
 
Subject Matter of the communication: Industry,  Health,  Science and Technology
 
Responsible Officer who filed this communication report: Pamela Fralick
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: